Inari Medical, Inc. (NARI) Financials
NARI Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 661.8 million | 214.5 million |
2023-12-31 | 674.2 million | 209.3 million |
2023-09-30 | 548.8 million | 96.7 million |
2023-06-30 | 525.0 million | 89.3 million |
NARI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -13.5 million | 12.9 million |
2023-12-31 | 9.8 million | 9.8 million |
2023-09-30 | 14.3 million | 9.8 million |
2023-06-30 | 8.5 million | 10.4 million |
NARI Net Income
No data available :(
NARI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 101.3 million | - | 31.5 million |
2023-12-31 | 116.1 million | - | 32.0 million |
2023-09-30 | 351.3 million | - | 32.3 million |
2023-06-30 | 337.5 million | - | 32.7 million |
NARI Shares Outstanding
NARI Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 1.3 million | 26.9 million | 103.1 million | - |
2023-12-31 | 2.4 million | 22.9 million | 91.5 million | 1.2 million |
2023-09-30 | 1.6 million | 21.5 million | 88.3 million | - |
2023-06-30 | 1.2 million | 21.1 million | 85.6 million | - |
NARI Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 143.2 million | 18.9 million |
2023-12-31 | 132.1 million | 18.1 million |
2023-09-30 | 126.4 million | 14.5 million |
2023-06-30 | 119.0 million | 13.8 million |
NARI
Price: $42.03
52 week price:
Earnings Per Share: -0.03 USD
P/E Ratio: -1164.80
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 1.7 million
Market Capitalization: 2.4 billion